Clinical Study on the Treatment of MIBC Patients With SHR-A2102 Injection Combined With Adebrelimab (SHR-1316)

Clinical trial NCT06879145 · RECRUITING

Trial details

NCT number: NCT06879145
Sponsor: Suzhou Suncadia Biopharmaceuticals Co., Ltd.
Status: RECRUITING
Phase: Phase 2, Phase 3
Study type: INTERVENTIONAL

Muscular Invasive Bladder Cancer (MIBC)

Start date: 2025-04-25
Primary completion: 2031-12-01
Enrollment: 840

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.